The Travelers Companies (TRV)
(Delayed Data from NYSE)
$240.88 USD
+0.76 (0.32%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $241.08 +0.20 (0.08%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$240.88 USD
+0.76 (0.32%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $241.08 +0.20 (0.08%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth F Momentum C VGM
Zacks News
Market Awaits Consumer Sentiment Data
by Zacks Equity Research
Market Awaits Consumer Sentiment Data
Pre-Markets Continue Bouncing Back; TRV +5% on Q4 News
by Mark Vickery
We've actually been on a relative plateau at current high levels since mid-December.
Here's What Key Metrics Tell Us About Travelers (TRV) Q4 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Travelers (TRV) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Travelers (TRV) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Travelers (TRV) delivered earnings and revenue surprises of 39.09% and 0.24%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Markets Rebound on Economic Prints, Fed Speak
by Mark Vickery
Tomorrow, we'll finish a content-heavy week with more economic grist for the mill.
4 P&C Insurance Stocks With Decent Dividend Yield to Bank on
by Sushmita Sarker
Here we pick four insurance stocks, CNA Financial (CNA), American Financial (AFG), Travelers Companies (TRV) and Axis Capital (AXS), which have a solid five-year dividend growth history.
The Zacks Analyst Blog Highlights Apple, Boeing, Coca-Cola, Procter & Gamble and Travelers
by Zacks Equity Research
Apple, Boeing, Coca-Cola, Procter & Gamble and Travelers are included in this Analyst Blog.
Progressive (PGR) to Report Q4 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
Progressive (PGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Buy CNA Financial (CNA) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Arthur J. Gallagher (AJG) Buys MGB, Boosts Medical Reinsurance
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of MGB is set to enhance the growth of its medical reinsurance business and expand service offerings.
5 Blue-Chip Stocks to Buy Ahead of Earnings Results
by Nalak Das
We have narrowed our search to five Dow stocks that are poised to beat on earnings results. These are: AAPL, KO, BA, PG, TRV.
Why The Travelers (TRV) Might Surprise This Earnings Season
by Zacks Equity Research
The Travelers (TRV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Is a Beat in Store for Travelers (TRV) This Earnings Season?
by Zacks Equity Research
Improved pricing, solid renewal rate change, strong retention and exposure growth are likely to aid Travelers Companies' (TRV) fourth-quarter results.
Gear Up for Travelers (TRV) Q4 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Travelers (TRV), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.
Markets Await Empire State Manufacturing Report
by Zacks Equity Research
Markets Await Empire State Manufacturing Report
Markets Closed in Remembrance of Dr. King
by Mark Vickery
Even though we're only just half way through the month, the lion's share of economic reports -- non-earnings-season-related -- have already happened for January.
How to Find Strong Finance Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Travelers (TRV) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Travelers (TRV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Travelers (TRV) Gains 15.8% in 6 Months: More Room to Run?
by Zacks Equity Research
Travelers (TRV) stock rallies on the back of strong net earned premiums, higher average levels of invested assets, improved results from the fixed-income portfolio and prudent capital deployment.
Is Axis Capital Holdings (AXS) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Arthur J. Gallagher (AJG) Adds Koberich to its Portfolio
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of Koberich is set to help it consolidate its presence in Europe.
Travelers (TRV) Boosts Cyber Capabilities With Corvus Buyout
by Zacks Equity Research
Travelers (TRV) buyout of Corvus Insurance marks its step toward enhancing its cyber capabilities, a part of its strategic growth roadmap.
Dow Hits New All-Time High, S&P Within 1%
by Mark Vickery
A late surge into the close has brought the blue-chip Down to a new all-time high: +251 points, +0.68%, to 37,557 for the first time ever.
4 Low-Beta P&C Insurance Stocks to Beat Volatile Market
by Tanuka De
Here we pick four low-beta stocks, ACGL, ALL, TRV and AXS, that are poised to deliver steady performance irrespective of market conditions.
TRV or ALL: Which P&C Insurance Stock Has an Edge Now?
by Zacks Equity Research
Let's see how Travelers Companies (TRV) and Allstate Corporation (ALL) fare in terms of some of the key metrics.